XPO1 and NUP214, two associated proteins whose regulatory targets are mutually upregulated in high-ColX module tumors, have collectively been described as drivers of breast cancer and markers of poor survival in pancreatic cancer. This evidence concerns the gene NUP214 and familial pancreatic carcinoma.